Arthroscopic Surgery Clinical Trial
Official title:
Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears
Verified date | September 2022 |
Source | Cedars-Sinai Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to compare outcomes and functionality measures of subjects treated with platelet rich plasma (PRP) after arthroscopic debridement of triangular fibrocartilage complex (TFCC) tears to subjects treated with arthroscopic debridement alone.
Status | Terminated |
Enrollment | 10 |
Est. completion date | February 6, 2021 |
Est. primary completion date | February 6, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Male or Female >18 years of age - triangular fibrocartilage complex (TFCC) tear requiring surgical intervention - Be willing to undergo arthroscopic debridement and injection with platelet-rich plasma (PRP) - Be in good health other than the TFCC tear - Have realistic expectations of surgical results - Understand and be willing to follow all aspects of the study protocol and have signed and dated the IRB-approved Informed Consent Form and the Authorization for Use and Release of Health and Research Study Information (HIPAA) form prior to any study-related procedures being performed Exclusion Criteria: - Have collagen-vascular, connective tissue, or bleeding disorders - Be a smoker or have smoked in last 2 months - Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability - Have regional sympathetic dystrophy - Be pregnant, lactating or expecting to be within the next 24 months - Currently have an alcohol/substance abuse problem or have had a relapse within one year to screening visit - Have an abscess or infection at the time of surgery - Have a condition or be in a situation that, in the Investigator's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study |
Country | Name | City | State |
---|---|---|---|
United States | Cedars-Sinai Department of Hand Surgery | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
Cedars-Sinai Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient-rated Wrist Evaluation (PRWE) Scores | The Patient-rated Wrist Evaluation is a 15 item patient-reported questionnaire to assess change from pre to post-op that asks the patient to rate their pain and function on a 10-point scale. 0 (minimum) means no pain/did not experience functional difficulties and 10 (maximum) means the worst pain/difficulty to function. Total minimum is 0 and total maximum for this scale measure is 150.
Compare Mean patient-rated Wrist Evaluation outcome scores from pre-op to post-op. |
change from pre to post-op | |
Primary | Modified Mayo Wrist Score - Grip Strength Score | Modified Mayo Wrist score - Grip strength score: A change in grip strength from pre to post-op (percentage of normal) - on 0 (minimum/total)-100% (maximum/total) scale between patients treated with PRP vs. patients not treated with PRP after arthroscopic debridement.
Compare mean (percentage of normal) Grip strength scores from pre-op to post-op. |
Up to 5 time points (change from pre to post-op): pre-op, post op: month 1, month 3, month 6 and year 1; Subjects will be followed for 12 months post arthroscopic debridement. | |
Primary | Modified Mayo Wrist Score - Pain Score | Modified Mayo Wrist score - Mean Pain score change assessment from pre to post-op: 0 (minimum/total; severe to intolerable)-25 (maximum/total; no pain) point scale | Up to 5 time points (change from pre to post-op): pre-op, post op: month 1, month 3, month 6 and year 1 | |
Primary | Modified Mayo Wrist Score - Range of Motion Score | Modified Mayo Wrist score - Range of motion score: Assessment of change from pre to post-op in patient's range of motion (percentage of normal) on a 0 (minimum/total)-100% (maximum/total) scale between mean patient score of patients treated with PRP vs. patients not treated with PRP after arthroscopic debridement. | Up to 5 time points (change from pre to post-op): pre-op, post op: month 1, month 3, month 6 and year 1; Subjects will be followed for 12 months post arthroscopic debridement. | |
Primary | Modified Mayo Wrist Score - Functional Status Score | Modified Mayo Wrist score - Functional status score: An assessment to review mean change from pre to post-op) 0 (minimum)-25 (maximum) point scale; a score of 0 denotes patient's inability to work because of pain and 25 denotes patients ability to work/return to regular employment | Up to 5 time points (change from pre to post-op): pre-op, post op: month 1, month 3, month 6 and year 1; Subjects will be followed for 12 months post arthroscopic debridement. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00739947 -
Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears
|
||
Not yet recruiting |
NCT06086223 -
Functional Outcomes Following Ankle Fracture Fixation With or Without Ankle Arthroscopy
|
N/A | |
Completed |
NCT06433154 -
Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL
|
||
Completed |
NCT05721547 -
Alterations in Spinal Alignment and Mobility in Individuals With Arthroscopic Rotator Cuff Repair
|
||
Completed |
NCT01254682 -
Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist
|
N/A |